search
Back to results

Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI

Primary Purpose

Prostate Cancer, Multiparametric MRI

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Deep learning based reconstruction of T2-TSE sequence
Sponsored by
University Hospital, Bonn
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Prostate Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria: Clinical suspicion of prostate cancer (PSA >4 ng/ml or suspicious digital rectal exam/transrectal ultrasound) Exclusion Criteria: General contraindications for MRI (cardiac pacemakers, neurostimulators, ferric metal) or gadolinium based contrast agents (GFR <30 ml/min/1.73 m2, prior severe allergic reactions) Severe claustrophobia

Sites / Locations

  • University Hospital Bonn

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Deep learning based reconstruction of T2-TSE sequence

Arm Description

Participants undergo multiparametric MRI of the prostate with inclusion of standard cartesian T2-TSE and non-cartesian T2-weighted sequences, as well as a newly developed deep learning enhanced T2-TSE sequence. All patients in this study undergo the same imaging protocol.

Outcomes

Primary Outcome Measures

Qualitative assessment of image quality (Artifacts, image sharpness, lesion conspicuity, capsule delineation, overall image quality and diagnostic confidence)
Artifacts, image sharpness, lesion conspicuity, capsule delineation, overall image quality and diagnostic confidence were rated on a 5-point-Likert-Scale with 1 being non-diagnostic and 5 being excellent. Friedman test was used for significance testing with p<0.05 considered as indicative of a significant difference.
Acquisition time
Measurement of acquisition time of T2-weighted sequences
Degree of agreement on PI-RADS ratings
To assess the PI-RADS score, all MRIs were read blinded by a radiologist with 11 years expertise at two different time points in random order. The MRI sequences for PI-RADS assessment included either T2NC (reference standard at our institution) or T2SR as the T2-weighted sequence in the reading protocol. The remainder of sequences were the same (axial T1-weighted TSE pre and post contrast administration, axial dynamically contrast enhanced T1, sagittal T2 TSE and axial diffusion weighted sequences with apparent diffusion coefficient map). Cohen's Kappa was used for correlation of readings with inclusion of either T2SR or T2NC.
Quantitative assessment of image quality (apparent signal-to-noise and contrast-to-noise ratio)
Apparent signal-to-noise ratio (aSNR: signal intensity of peripheral zone/standard deviation of muscle) and contrast-to-noise ratio (aCNR: signal intensity of peripheral zone - signal intensity of muscle)/standard deviation of muscle) was calculated to quantify the image sharpness. One-way ANOVA was used for significance testing with p<0.05 considered as indicative of a significant difference.
Quantitative assessment of image quality (edge rise distance)
Edge rise distance (ERD) was calculated to quantify the image sharpness. The ERD was determined as a measure of image sharpness. For this purpose, a line was drawn perpendicularly crossing the dorsal border of the prostate capsule. The edge rise distance was then determined as the distance (in mm) between the 10% and 90% signal intensity levels relative to the low and high signal intensity areas. One-way ANOVA was used for significance testing with p<0.05 considered as indicative of a significant difference.

Secondary Outcome Measures

Full Information

First Posted
February 6, 2023
Last Updated
April 6, 2023
Sponsor
University Hospital, Bonn
Collaborators
Philips Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT05820113
Brief Title
Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
Official Title
Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
August 1, 2022 (Actual)
Primary Completion Date
November 30, 2022 (Actual)
Study Completion Date
November 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Bonn
Collaborators
Philips Healthcare

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
The aim of this study was therefore to investigate a new unrolled DL super resolution reconstruction of an initially low-resolution Cartesian T2 turbo spin echo sequence (T2 TSE) and compare it qualitatively and quantitatively to standard high-resolution Cartesian and non-Cartesian T2 TSE sequences in the setting of prostate mpMRI with particular interest in image sharpness, conspicuity of lesions and acquisition time. Furthermore, the investigators assessed the agreement of assigned PI-RADS scores between deep learning super resolution and standard sequences.
Detailed Description
Prostate cancer has been among the most prevalent cancer types in men for years, being responsible for 7.8% of all newly diagnosed cases in 2020, holding the 2th place right after lung cancer. Early and non-invasive diagnostics was improved vastly by multiparametric MRI (mpMRI) of the prostate, detecting clinically significant prostate cancer and forming the baseline for guided biopsy of the prostate, while it can prevent unnecessary biopsies in patients with elevated prostate specific antigen, but no visible lesions. With an aging population fast, efficient and highly qualitative MRI scans are needed to satisfy this increasing demand. Deep learning image reconstruction has become increasingly important solving these tasks to produce highly qualitative images while drastically reducing acquisition time. Standard acquisition protocols of prostate mpMRI include T2-weighted, diffusion-weighted and dynamically contrast-enhanced sequences to allow for the classification of prostatic lesions according to the Prostate Imaging Reporting & Data System (PI-RADS). While the assignment of the PI-RADS score in the peripheral zone of the prostate is mainly determined by the diffusion weighted imaging, the T2-weighted-sequences are mainly responsible for the assessment of the transitional zone. Furthermore, thorough assessment of the prostate necessitates acquisition of T2-weighted sequences in axial and sagittal planes, thus extending acquisition time of MRI protocols. Different approaches have been proposed to accelerate and improve the image acquisition, ranging from the implementation of shortened protocols to the improvement of diffusion weighted sequences or using compressed sensing for the reconstruction of non-Cartesian T2-weighted-sequences. Besides these methods that rely on traditional acquisition and reconstruction methods, deep learning (DL) image reconstruction has become increasingly important solving these tasks to produce highly qualitative images while drastically reducing acquisition time. Despite that, reliable DL-methods for the process of image acquisition and reconstruction of prostate mpMRI itself are sparse. While first approaches for DL denoising has been established, effectively replacing the conventional wavelet function, the remainder of the iterative reconstruction cycle is unaffected and the impact on diagnostic performance of the PI-RADS score remains unclear. Recently developed super resolution deep learning networks are promising to overcome this limitation. First results for DL denoising in different applications, e.g. in musculoskeletal MRI already show good results, leading to significant acceleration of acquisition time while maintaining high image quality. However, the application of these denoising DL-networks in combination with more advanced super resolution networks in prostate mpMRI hasn't been evaluated yet. In this prospective study, between August and November 2022, participants with suspicion for prostate cancer underwent prostate MRI with standard high-resolution Cartesian T2 (T2C) and non-Cartesian T2 (T2NC) sequences. Additionally, a low-resolution Cartesian T2 TSE (T2SR) with DL denoising and super resolution reconstruction was acquired. Artifacts, image sharpness, lesion conspicuity, capsule delineation, overall image quality and diagnostic confidence were rated on a 5-point-Likert-Scale with being non-diagnostic and 5 being excellent. Apparent signal-to-noise ratio (aSNR), contrast-to-noise ratio (aCNR) and edge rise distance (ERD) were calculated. Friedman test and One-way ANOVA were used for group comparisons. Regarding agreement of PI-RADS scores were compared with Cohen's Kappa.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer, Multiparametric MRI

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
109 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Deep learning based reconstruction of T2-TSE sequence
Arm Type
Experimental
Arm Description
Participants undergo multiparametric MRI of the prostate with inclusion of standard cartesian T2-TSE and non-cartesian T2-weighted sequences, as well as a newly developed deep learning enhanced T2-TSE sequence. All patients in this study undergo the same imaging protocol.
Intervention Type
Device
Intervention Name(s)
Deep learning based reconstruction of T2-TSE sequence
Intervention Description
A newly developed deep-learning based reconstruction of a primarily low-resolved T2-TSE sequence is included in the imaging protocol for evaluation of prostate cancer.
Primary Outcome Measure Information:
Title
Qualitative assessment of image quality (Artifacts, image sharpness, lesion conspicuity, capsule delineation, overall image quality and diagnostic confidence)
Description
Artifacts, image sharpness, lesion conspicuity, capsule delineation, overall image quality and diagnostic confidence were rated on a 5-point-Likert-Scale with 1 being non-diagnostic and 5 being excellent. Friedman test was used for significance testing with p<0.05 considered as indicative of a significant difference.
Time Frame
4 months
Title
Acquisition time
Description
Measurement of acquisition time of T2-weighted sequences
Time Frame
4 months
Title
Degree of agreement on PI-RADS ratings
Description
To assess the PI-RADS score, all MRIs were read blinded by a radiologist with 11 years expertise at two different time points in random order. The MRI sequences for PI-RADS assessment included either T2NC (reference standard at our institution) or T2SR as the T2-weighted sequence in the reading protocol. The remainder of sequences were the same (axial T1-weighted TSE pre and post contrast administration, axial dynamically contrast enhanced T1, sagittal T2 TSE and axial diffusion weighted sequences with apparent diffusion coefficient map). Cohen's Kappa was used for correlation of readings with inclusion of either T2SR or T2NC.
Time Frame
4 months
Title
Quantitative assessment of image quality (apparent signal-to-noise and contrast-to-noise ratio)
Description
Apparent signal-to-noise ratio (aSNR: signal intensity of peripheral zone/standard deviation of muscle) and contrast-to-noise ratio (aCNR: signal intensity of peripheral zone - signal intensity of muscle)/standard deviation of muscle) was calculated to quantify the image sharpness. One-way ANOVA was used for significance testing with p<0.05 considered as indicative of a significant difference.
Time Frame
4 months
Title
Quantitative assessment of image quality (edge rise distance)
Description
Edge rise distance (ERD) was calculated to quantify the image sharpness. The ERD was determined as a measure of image sharpness. For this purpose, a line was drawn perpendicularly crossing the dorsal border of the prostate capsule. The edge rise distance was then determined as the distance (in mm) between the 10% and 90% signal intensity levels relative to the low and high signal intensity areas. One-way ANOVA was used for significance testing with p<0.05 considered as indicative of a significant difference.
Time Frame
4 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical suspicion of prostate cancer (PSA >4 ng/ml or suspicious digital rectal exam/transrectal ultrasound) Exclusion Criteria: General contraindications for MRI (cardiac pacemakers, neurostimulators, ferric metal) or gadolinium based contrast agents (GFR <30 ml/min/1.73 m2, prior severe allergic reactions) Severe claustrophobia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julian A Luetkens, PD Dr. med.
Organizational Affiliation
University Hospital, Bonn
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Bonn
City
Bonn
State/Province
NRW
ZIP/Postal Code
53127
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33538338
Citation
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
Results Reference
background
PubMed Identifier
34237810
Citation
Eklund M, Jaderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, Glaessgen A, Carlsson S, Gronberg H, Nordstrom T; STHLM3 consortium. MRI-Targeted or Standard Biopsy in Prostate Cancer Screening. N Engl J Med. 2021 Sep 2;385(10):908-920. doi: 10.1056/NEJMoa2100852. Epub 2021 Jul 9.
Results Reference
background
PubMed Identifier
36477032
Citation
Hugosson J, Mansson M, Wallstrom J, Axcrona U, Carlsson SV, Egevad L, Geterud K, Khatami A, Kohestani K, Pihl CG, Socratous A, Stranne J, Godtman RA, Hellstrom M; GOTEBORG-2 Trial Investigators. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. N Engl J Med. 2022 Dec 8;387(23):2126-2137. doi: 10.1056/NEJMoa2209454.
Results Reference
background
Citation
ACR, ESUR and AdMeTech Foundation. Prostate Imaging Reporting & Data System (PI-RADS). 2019. Version 2.1.
Results Reference
background
PubMed Identifier
29077588
Citation
Weiss J, Martirosian P, Notohamiprodjo M, Kaufmann S, Othman AE, Grosse U, Nikolaou K, Gatidis S. Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy. Invest Radiol. 2018 Mar;53(3):186-190. doi: 10.1097/RLI.0000000000000427.
Results Reference
background
PubMed Identifier
34049334
Citation
Langbein BJ, Szczepankiewicz F, Westin CF, Bay C, Maier SE, Kibel AS, Tempany CM, Fennessy FM. A Pilot Study of Multidimensional Diffusion MRI for Assessment of Tissue Heterogeneity in Prostate Cancer. Invest Radiol. 2021 Dec 1;56(12):845-853. doi: 10.1097/RLI.0000000000000796.
Results Reference
background
PubMed Identifier
36070533
Citation
Bischoff LM, Katemann C, Isaak A, Mesropyan N, Wichtmann B, Kravchenko D, Endler C, Kuetting D, Pieper CC, Ellinger J, Weber O, Attenberger U, Luetkens JA. T2 Turbo Spin Echo With Compressed Sensing and Propeller Acquisition (Sampling k-Space by Utilizing Rotating Blades) for Fast and Motion Robust Prostate MRI: Comparison With Conventional Acquisition. Invest Radiol. 2023 Mar 1;58(3):209-215. doi: 10.1097/RLI.0000000000000923. Epub 2022 Sep 2.
Results Reference
background
PubMed Identifier
29777175
Citation
Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018 Aug;18(8):500-510. doi: 10.1038/s41568-018-0016-5.
Results Reference
background
PubMed Identifier
36497223
Citation
Harder FN, Weiss K, Amiel T, Peeters JM, Tauber R, Ziegelmayer S, Burian E, Makowski MR, Sauter AP, Gschwend JE, Karampinos DC, Braren RF. Prospectively Accelerated T2-Weighted Imaging of the Prostate by Combining Compressed SENSE and Deep Learning in Patients with Histologically Proven Prostate Cancer. Cancers (Basel). 2022 Nov 22;14(23):5741. doi: 10.3390/cancers14235741.
Results Reference
background
PubMed Identifier
26761735
Citation
Dong C, Loy CC, He K, Tang X. Image Super-Resolution Using Deep Convolutional Networks. IEEE Trans Pattern Anal Mach Intell. 2016 Feb;38(2):295-307. doi: 10.1109/TPAMI.2015.2439281.
Results Reference
background
Citation
11. Li Y, Sixou B, Peyrin F. A Review of the Deep Learning Methods for Medical Images Super Resolution Problems. IRBM, Volume 42, Issue 2, April 2021, Pages 120-133. doi: 10.1016/j.irbm.2020.08.004
Results Reference
background
PubMed Identifier
36318032
Citation
Almansour H, Herrmann J, Gassenmaier S, Afat S, Jacoby J, Koerzdoerfer G, Nickel D, Mostapha M, Nadar M, Othman AE. Deep Learning Reconstruction for Accelerated Spine MRI: Prospective Analysis of Interchangeability. Radiology. 2023 Mar;306(3):e212922. doi: 10.1148/radiol.212922. Epub 2022 Nov 1.
Results Reference
background
PubMed Identifier
35776434
Citation
Kim M, Lee SM, Park C, Lee D, Kim KS, Jeong HS, Kim S, Choi MH, Nickel D. Deep Learning-Enhanced Parallel Imaging and Simultaneous Multislice Acceleration Reconstruction in Knee MRI. Invest Radiol. 2022 Dec 1;57(12):826-833. doi: 10.1097/RLI.0000000000000900. Epub 2022 Jul 1.
Results Reference
background
Citation
Pezzotti N, de Weerdt E, Yousefi S, et al. Adaptive-CS-Net: FastMRI with Adaptive Intelligence. arxiv:1912.12259. 2019;(NeurIPS).
Results Reference
background
Citation
Zhang J and Ghanem B. ISTA-Net: Interpretable optimization-inspired deep network for image compressive sensing. Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, 2018, pp. 1828-1837
Results Reference
background
Citation
Kim J, Lee JK, Lee KM. Accurate Image Super-Resolution Using Very Deep Convolutional Networks. arXiv:1511.04587
Results Reference
background
PubMed Identifier
29582464
Citation
Chaudhari AS, Fang Z, Kogan F, Wood J, Stevens KJ, Gibbons EK, Lee JH, Gold GE, Hargreaves BA. Super-resolution musculoskeletal MRI using deep learning. Magn Reson Med. 2018 Nov;80(5):2139-2154. doi: 10.1002/mrm.27178. Epub 2018 Mar 26.
Results Reference
background
PubMed Identifier
22436433
Citation
Suzuki S, Machida H, Tanaka I, Ueno E. Measurement of vascular wall attenuation: comparison of CT angiography using model-based iterative reconstruction with standard filtered back-projection algorithm CT in vitro. Eur J Radiol. 2012 Nov;81(11):3348-53. doi: 10.1016/j.ejrad.2012.02.009. Epub 2012 Mar 19.
Results Reference
background
Citation
Agarwal S, Singh O.P, Nagaria D. Analysis and Comparison of Wavelet Transforms for Denoising MRI Image. Biomed Pharmacol J 2017;10(2).
Results Reference
background
PubMed Identifier
36765539
Citation
Gassenmaier S, Warm V, Nickel D, Weiland E, Herrmann J, Almansour H, Wessling D, Afat S. Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction. Cancers (Basel). 2023 Jan 18;15(3):578. doi: 10.3390/cancers15030578.
Results Reference
background
PubMed Identifier
35103536
Citation
Ueda T, Ohno Y, Yamamoto K, Murayama K, Ikedo M, Yui M, Hanamatsu S, Tanaka Y, Obama Y, Ikeda H, Toyama H. Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging. Radiology. 2022 May;303(2):373-381. doi: 10.1148/radiol.204097. Epub 2022 Feb 1.
Results Reference
background
PubMed Identifier
34877735
Citation
Johnson PM, Tong A, Donthireddy A, Melamud K, Petrocelli R, Smereka P, Qian K, Keerthivasan MB, Chandarana H, Knoll F. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate. J Magn Reson Imaging. 2022 Jul;56(1):184-195. doi: 10.1002/jmri.28024. Epub 2021 Dec 7.
Results Reference
background
PubMed Identifier
24408499
Citation
Wright KL, Hamilton JI, Griswold MA, Gulani V, Seiberlich N. Non-Cartesian parallel imaging reconstruction. J Magn Reson Imaging. 2014 Nov;40(5):1022-40. doi: 10.1002/jmri.24521. Epub 2014 Jan 10.
Results Reference
background
PubMed Identifier
25630632
Citation
Zaitsev M, Maclaren J, Herbst M. Motion artifacts in MRI: A complex problem with many partial solutions. J Magn Reson Imaging. 2015 Oct;42(4):887-901. doi: 10.1002/jmri.24850. Epub 2015 Jan 28.
Results Reference
background

Learn more about this trial

Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI

We'll reach out to this number within 24 hrs